Andon Health Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	1,556	2,578	3,172	26,265	2,340	1,996
Other Revenue	13.85	13.85	58.66	50.51	57.06	11.9
Revenue	1,569	2,592	3,231	26,315	2,397	2,008
Revenue Growth (YoY)	-39.13%	-19.77%	-87.72%	997.80%	19.36%	184.36%
Cost of Revenue	562.48	784.96	1,275	5,529	884.82	906.6
Gross Profit	1,007	1,807	1,956	20,786	1,512	1,102
Selling, General & Admin	922.08	863.38	886.05	2,004	496.55	592.82
Research & Development	306.77	260.69	278.46	264.89	66.73	76.54
Other Operating Expenses	4.5	3.4	41.6	4.15	6.25	7.34
Operating Expenses	1,242	1,130	1,203	2,286	592.96	686.29
Operating Income	-235.38	677.15	752.66	18,500	919.31	415.47
Interest Expense	-106.91	-67.16	-12.43	-4.75	-13.3	-6.95
Interest & Investment Income	875.11	800.45	735.36	274.1	62.35	327.17
Currency Exchange Gain (Loss)	-11.92	-11.92	40.13	35.26	-2.2	-18.8
Other Non Operating Income (Expenses)	0.27	-2.26	-2.8	-1.98	-3.86	-2.65
EBT Excluding Unusual Items	521.16	1,396	1,513	18,803	962.29	714.23
Impairment of Goodwill	-	-	-89.5	-125.26	-	-123.43
Gain (Loss) on Sale of Investments	1,394	735.6	309.29	-326.4	30.49	-336.92
Gain (Loss) on Sale of Assets	0.94	0.67	-0.5	-6.43	0.01	-0.03
Asset Writedown	-30.6	-25.45	-153.14	-46.95	-1.88	-24.29
Other Unusual Items	1.02	-0.2	1.28	-39.85	8.72	10.19
Pretax Income	1,886	2,107	1,580	18,258	999.63	239.75
Income Tax Expense	31.82	306.83	231.11	1,774	65.23	2.92
Earnings From Continuing Operations	1,854	1,800	1,349	16,484	934.4	236.83
Minority Interest in Earnings	34.93	-131.31	-97.62	-453.93	-25.76	5.5
Net Income	1,889	1,669	1,252	16,030	908.64	242.33
Net Income to Common	1,889	1,669	1,252	16,030	908.64	242.33
Net Income Growth	9.61%	33.33%	-92.19%	1664.19%	274.96%	264.68%
Shares Outstanding (Basic)	441	438	445	456	455	433
Shares Outstanding (Diluted)	442	441	452	467	455	433
Shares Change (YoY)	5.76%	-2.49%	-3.23%	2.82%	5.02%	-2.30%
EPS (Basic)	4.28	3.81	2.81	35.14	2.00	0.56
EPS (Diluted)	4.27	3.78	2.77	34.30	2.00	0.56
EPS Growth	3.64%	36.73%	-91.93%	1615.80%	257.03%	273.27%
Free Cash Flow	-11.34	912.83	1,557	18,010	222.67	407.85
Free Cash Flow Per Share	-0.03	2.07	3.44	38.53	0.49	0.94
Dividend Per Share	0.200	0.200	0.300	2.500	0.700	0.060
Dividend Growth	-33.33%	-33.33%	-88.00%	257.14%	1066.67%	-
Gross Margin	64.16%	69.72%	60.54%	78.99%	63.09%	54.86%
Operating Margin	-15.00%	26.12%	23.29%	70.30%	38.35%	20.69%
Profit Margin	120.37%	64.38%	38.74%	60.92%	37.91%	12.07%
Free Cash Flow Margin	-0.72%	35.22%	48.20%	68.44%	9.29%	20.31%
EBITDA	-236.17	709.44	829.08	18,574	985.28	478.25
EBITDA Margin	-15.05%	27.37%	25.66%	70.58%	41.10%	23.81%
D&A For EBITDA	-0.79	32.3	76.42	74.18	65.97	62.78
EBIT	-235.38	677.15	752.66	18,500	919.31	415.47
EBIT Margin	-15.00%	26.12%	23.29%	70.30%	38.35%	20.69%
Effective Tax Rate	1.69%	14.56%	14.62%	9.71%	6.53%	1.22%
Revenue as Reported	1,569	2,592	3,231	26,315	2,397	2,008
Advertising Expenses	-	108.82	82.77	70.38	51.22	84.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.